Iron supplementation for anemia
Pro Research Analysisby 
Searched over 200M research papers
Iron Supplementation for Anemia: Efficacy and Strategies
Oral Iron Supplementation: Effectiveness and Tolerability
Oral iron supplementation is the primary treatment for iron-deficiency anemia and is generally effective in correcting anemia and replenishing iron stores in most populations, including children, adolescents, and menstruating women 23710. Ferrous sulfate is the most commonly used and affordable oral iron, but newer formulations like ferric maltol and sucrosomial® iron have also been developed to improve tolerability . However, gastrointestinal side effects such as constipation, diarrhea, and abdominal pain are common and can reduce adherence to treatment 27.
Dosing Regimens: Daily vs. Intermittent and Alternate-Day Supplementation
Daily iron supplementation significantly reduces anemia prevalence, increases hemoglobin, and improves iron stores, but is associated with more gastrointestinal side effects . Intermittent regimens (one to three times per week) are nearly as effective as daily dosing for improving hemoglobin and reducing anemia, with fewer side effects, making them a suitable alternative for menstruating women and populations with high anemia prevalence . Studies comparing daily and alternate-day dosing found no significant difference in hemoglobin improvement, suggesting both regimens are similarly effective .
Optimal Dose and Duration in Children and Adolescents
For children and adolescents, low-dose iron supplementation (<5 mg/kg/day) for less than 3 months or more than 6 months is optimal for improving hemoglobin levels, especially in those with lower baseline hemoglobin . Tailoring the dose and duration based on anemia severity and baseline hemoglobin is important for maximizing benefit and minimizing side effects .
Predicting and Monitoring Response to Oral Iron
A hemoglobin increase of at least 1.0 g/dL after 14 days of oral iron therapy is a strong predictor of a satisfactory response by 6–8 weeks. Patients who do not achieve this threshold may benefit from switching to intravenous iron supplementation . Oral iron therapy also improves quality of life and reduces fatigue in responders .
Special Populations: Chronic Kidney Disease and Acute Bleeding
In patients with chronic kidney disease, intravenous iron is generally more effective than oral iron, especially after dialysis initiation. Certain IV formulations, such as ferumoxytol and ferric carboxymaltose, are particularly potent . For anemia secondary to acute upper gastrointestinal bleeding, oral iron supplementation after discharge can help restore hemoglobin and iron stores, though more research is needed in this area .
School-Based and Community Interventions
School-based weekly iron-folic acid supplementation can modestly improve hemoglobin in adolescents, but may not be sufficient alone to significantly reduce anemia prevalence. Combining supplementation with other interventions may be necessary for greater impact .
Conclusion
Iron supplementation, particularly oral iron, is effective for treating iron-deficiency anemia across various populations. Daily and intermittent regimens are both effective, with intermittent dosing offering better tolerability. Monitoring early hemoglobin response helps identify those who may need intravenous iron. Tailoring dose and duration to individual needs and considering population-specific strategies can optimize outcomes and minimize side effects 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic